Deutsche Bank
PBE icon

Deutsche Bank’s Invesco Biotechnology & Genome ETF PBE Stock Holding History

Deutsche Bank’s Portfolio PBE Stock Details PBE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-116
Closed -$5K – 5710
2014
Q4 		$5K Sell
116
-13,172
-99% -$645K ﹤0.01% 5882
2014
Q3 		$614K Buy
13,288
+822
+7% +$37K ﹤0.01% 3350
2014
Q2 		$544K Buy
12,466
+186
+2% +$7.54K ﹤0.01% 3405
2014
Q1 		$511K Buy
12,280
+2,154
+21% +$92.2K ﹤0.01% 3322
2013
Q4 		$375K Buy
+10,126
New +$363K ﹤0.01% 3307

Other funds holding PBE

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
TAM
Trillium Asset Management Boston, Massachusetts $3.01B AUM 19.96% 1-Year Est. Return
QA
Quantitative Advantage Minnetonka, Minnesota $689M AUM 6.25% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
TCM
Traynor Capital Management Malvern, Pennsylvania $1.7B AUM 39.15% 1-Year Est. Return

Deutsche Bank's PBE Position: Q1 2015 in Review

Deutsche Bank sold out of Invesco Biotechnology & Genome ETF (PBE) in Q1 2015, closing a stake of 116 shares — an estimated $5K sold.

Deutsche Bank first reported a position in PBE in Q4 2013 and held it in 5 quarters. The position peaked at $614K in Q3 2014. 87 funds tracked by Wall St. Rank hold PBE as of Q1 2015.

  • Deutsche Bank reported no remaining Invesco Biotechnology & Genome ETF position as of Q1 2015 after selling out during the quarter.
  • Deutsche Bank sold 116 Invesco Biotechnology & Genome ETF shares in Q1 2015, an estimated $5K.
  • Deutsche Bank first reported a position in Invesco Biotechnology & Genome ETF in Q4 2013 and held it in 5 quarters.
  • Deutsche Bank's Invesco Biotechnology & Genome ETF position peaked at $614K in Q3 2014.
  • 87 funds tracked by Wall St. Rank held Invesco Biotechnology & Genome ETF as of Q1 2015.

Based on Deutsche Bank's 13F filing for Q1 2015, filed 15 May 2015.